ASX - By Stock
|
GMV |
Re:
GMVD Nasdaq
|
|
axbci
|
827 |
292K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
827
|
292K
|
0
|
|
ASX - By Stock
|
GMV |
Re:
GMVD Nasdaq
|
|
axbci
|
827 |
292K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
827
|
292K
|
0
|
|
ASX - By Stock
|
GMV |
Re:
GMVD Nasdaq
|
|
axbci
|
827 |
292K |
2 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
827
|
292K
|
2
|
|
ASX - By Stock
|
GMV |
Re:
IPO update
|
|
axbci
|
1.5K |
466K |
1 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
1.5K
|
466K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
IPO update
|
|
axbci
|
1.5K |
466K |
6 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
1.5K
|
466K
|
6
|
|
ASX - By Stock
|
GMV |
Re:
IPO update
|
|
axbci
|
1.5K |
466K |
7 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
1.5K
|
466K
|
7
|
|
ASX - By Stock
|
GMV |
Re:
IPO update
|
|
axbci
|
1.5K |
466K |
5 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
1.5K
|
466K
|
5
|
|
ASX - By Stock
|
GMV |
Re:
IPO update
|
|
axbci
|
1.5K |
466K |
2 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
1.5K
|
466K
|
2
|
|
ASX - By Stock
|
GMV |
Re:
IPO update
|
|
axbci
|
1.5K |
466K |
4 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
1.5K
|
466K
|
4
|
|
ASX - By Stock
|
GMV |
Re:
IPO update
|
|
axbci
|
1.5K |
466K |
10 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
1.5K
|
466K
|
10
|
|
ASX - By Stock
|
GMV |
Re:
IPO update
|
|
axbci
|
1.5K |
466K |
4 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
1.5K
|
466K
|
4
|
|
ASX - By Stock
|
GMV |
Re:
IPO update
|
|
axbci
|
1.5K |
466K |
11 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
1.5K
|
466K
|
11
|
|
ASX - By Stock
|
GMV |
Re:
IPO update
|
|
axbci
|
1.5K |
466K |
2 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
1.5K
|
466K
|
2
|
|
ASX - By Stock
|
GMV |
Re:
GMVD - NASDAQ IPO
|
|
axbci
|
1.9K |
682K |
8 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
1.9K
|
682K
|
8
|
|
ASX - By Stock
|
GMV |
Re:
GMVD - NASDAQ IPO
|
|
axbci
|
1.9K |
682K |
4 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
1.9K
|
682K
|
4
|
|
ASX - By Stock
|
GMV |
Re:
GMVD - NASDAQ IPO
|
|
axbci
|
1.9K |
682K |
2 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
1.9K
|
682K
|
2
|
|
ASX - By Stock
|
GMV |
Re:
GMVD - NASDAQ IPO
|
|
axbci
|
1.9K |
682K |
8 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
1.9K
|
682K
|
8
|
|
ASX - By Stock
|
GMV |
Re:
GMVD - NASDAQ IPO
|
|
axbci
|
1.9K |
682K |
9 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
1.9K
|
682K
|
9
|
|
ASX - By Stock
|
GMV |
Re:
GMVD - NASDAQ IPO
|
|
axbci
|
1.9K |
682K |
12 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
1.9K
|
682K
|
12
|
|
ASX - By Stock
|
GMV |
Re:
GMVD - NASDAQ IPO
|
|
axbci
|
1.9K |
682K |
5 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
1.9K
|
682K
|
5
|
|
ASX - By Stock
|
GMV |
Re:
GMVD - NASDAQ IPO
|
|
axbci
|
1.9K |
682K |
5 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
1.9K
|
682K
|
5
|
|
ASX - By Stock
|
GMV |
Re:
GMVD - NASDAQ IPO
|
|
axbci
|
1.9K |
682K |
14 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
1.9K
|
682K
|
14
|
|
ASX - By Stock
|
GMV |
Re:
Ann: ASX Confirms G Medical Delisting
|
|
axbci
|
355 |
100K |
8 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
355
|
100K
|
8
|
|
ASX - By Stock
|
GMV |
Re:
Ann: ASX Confirms G Medical Delisting
|
|
axbci
|
355 |
100K |
5 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
355
|
100K
|
5
|
|
ASX - By Stock
|
GMV |
Re:
Ann: General Meeting Dial-In Details
|
|
axbci
|
95 |
25K |
3 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
95
|
25K
|
3
|
|
ASX - By Stock
|
GMV |
Re:
Ann: General Meeting Dial-In Details
|
|
axbci
|
95 |
25K |
5 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
95
|
25K
|
5
|
|
ASX - By Stock
|
GMV |
Re:
Ann: General Meeting Dial-In Details
|
|
axbci
|
95 |
25K |
2 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
95
|
25K
|
2
|
|
ASX - By Stock
|
GMV |
Re:
Ann: G Medical Continues Rapid Growth in USA
|
|
axbci
|
157 |
54K |
2 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
157
|
54K
|
2
|
|
ASX - By Stock
|
GMV |
Re:
Ann: G Medical Continues Rapid Growth in USA
|
|
axbci
|
157 |
54K |
6 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
157
|
54K
|
6
|
|
ASX - By Stock
|
GMV |
Re:
Ann: G Medical Continues Rapid Growth in USA
|
|
axbci
|
157 |
54K |
12 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
157
|
54K
|
12
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Half Year Accounts
|
|
axbci
|
125 |
29K |
13 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
125
|
29K
|
13
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Half Year Accounts
|
|
axbci
|
125 |
29K |
3 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
125
|
29K
|
3
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Half Year Accounts
|
|
axbci
|
125 |
29K |
12 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
125
|
29K
|
12
|
|
ASX - By Stock
|
GMV |
Re:
Ann: G Medical seeks delisting to pursue Q4 NASDAQ listing
|
|
axbci
|
687 |
185K |
0 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
687
|
185K
|
0
|
|
ASX - By Stock
|
GMV |
Re:
Ann: G Medical seeks delisting to pursue Q4 NASDAQ listing
|
|
axbci
|
687 |
185K |
8 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
687
|
185K
|
8
|
|
ASX - By Stock
|
GMV |
Re:
GMV The Future
|
|
axbci
|
3.0K |
1.7M |
3 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
3.0K
|
1.7M
|
3
|
|
ASX - By Stock
|
GMV |
Re:
GMV The Future
|
|
axbci
|
3.0K |
1.7M |
12 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
3.0K
|
1.7M
|
12
|
|
ASX - By Stock
|
GMV |
Re:
GMV The Future
|
|
axbci
|
3.0K |
1.7M |
2 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
3.0K
|
1.7M
|
2
|
|
ASX - By Stock
|
GMV |
Re:
GMV The Future
|
|
axbci
|
3.0K |
1.7M |
8 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
3.0K
|
1.7M
|
8
|
|
ASX - By Stock
|
GMV |
Re:
GMV The Future
|
|
axbci
|
3.0K |
1.7M |
5 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
3.0K
|
1.7M
|
5
|
|
ASX - By Stock
|
GMV |
Re:
GMV The Future
|
|
axbci
|
3.0K |
1.7M |
5 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
3.0K
|
1.7M
|
5
|
|
ASX - By Stock
|
GMV |
Re:
GMV The Future
|
|
axbci
|
3.0K |
1.7M |
9 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
3.0K
|
1.7M
|
9
|
|
ASX - By Stock
|
GMV |
Re:
GMV The Future
|
|
axbci
|
3.0K |
1.7M |
2 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
3.0K
|
1.7M
|
2
|
|
ASX - By Stock
|
GMV |
Re:
GMV The Future
|
|
axbci
|
3.0K |
1.7M |
14 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
3.0K
|
1.7M
|
14
|
|
ASX - By Stock
|
GMV |
Re:
Ann: $5 million Capital Raising to Support Growth
|
|
axbci
|
42 |
15K |
7 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
42
|
15K
|
7
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
axbci
|
55 |
17K |
3 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
55
|
17K
|
3
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
axbci
|
55 |
17K |
6 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
55
|
17K
|
6
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Update on continued expansion of IDTF platform in USA
|
|
axbci
|
131 |
38K |
4 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
131
|
38K
|
4
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Update on continued expansion of IDTF platform in USA
|
|
axbci
|
131 |
38K |
5 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
131
|
38K
|
5
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Update on continued expansion of IDTF platform in USA
|
|
axbci
|
131 |
38K |
5 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
131
|
38K
|
5
|
|